Tonix Pharmaceuticals Holding Corp (TNXP)
0.1891
-0.02
(-7.39%)
USD |
NASDAQ |
Nov 22, 16:00
0.1807
-0.01
(-4.44%)
After-Hours: 20:00
Tonix Pharmaceuticals Cash from Operations (Quarterly): -18.80M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -18.80M |
| June 30, 2024 | -9.919M |
| March 31, 2024 | -17.58M |
| December 31, 2023 | -22.34M |
| September 30, 2023 | -23.38M |
| June 30, 2023 | -23.37M |
| March 31, 2023 | -32.91M |
| December 31, 2022 | -22.30M |
| September 30, 2022 | -23.54M |
| June 30, 2022 | -21.17M |
| March 31, 2022 | -31.05M |
| December 31, 2021 | -22.44M |
| September 30, 2021 | -12.95M |
| June 30, 2021 | -19.11M |
| March 31, 2021 | -21.06M |
| December 31, 2020 | -13.91M |
| September 30, 2020 | -15.28M |
| June 30, 2020 | -10.04M |
| March 31, 2020 | -9.326M |
| December 31, 2019 | -6.683M |
| September 30, 2019 | -6.645M |
| June 30, 2019 | -4.713M |
| March 31, 2019 | -8.642M |
| December 31, 2018 | -6.824M |
| September 30, 2018 | -4.891M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.485M |
| March 31, 2018 | -6.771M |
| December 31, 2017 | -4.927M |
| September 30, 2017 | -5.047M |
| June 30, 2017 | -4.36M |
| March 31, 2017 | -4.794M |
| December 31, 2016 | -5.441M |
| September 30, 2016 | -8.392M |
| June 30, 2016 | -7.995M |
| March 31, 2016 | -15.48M |
| December 31, 2015 | -11.91M |
| September 30, 2015 | -12.32M |
| June 30, 2015 | -9.238M |
| March 31, 2015 | -9.053M |
| December 31, 2014 | -8.218M |
| September 30, 2014 | -4.859M |
| June 30, 2014 | -5.699M |
| March 31, 2014 | -4.064M |
| December 31, 2013 | -3.531M |
| September 30, 2013 | -2.863M |
| June 30, 2013 | -0.761M |
| March 31, 2013 | -1.362M |
| December 31, 2012 | -1.505M |
| September 30, 2012 | -1.300M |
| June 30, 2012 | -1.130M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-32.91M
Minimum
Mar 2023
-6.683M
Maximum
Dec 2019
-18.86M
Average
-20.08M
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.705B |
| Emergent BioSolutions Inc | 153.70M |
| Geovax Labs Inc | -9.297M |
| Amicus Therapeutics Inc | -22.97M |
| Chimerix Inc | -20.51M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.009M |
| Cash from Financing (Quarterly) | 42.90M |
| Free Cash Flow | -69.19M |
| Free Cash Flow Per Share (Quarterly) | -0.3028 |
| Free Cash Flow to Equity (Quarterly) | -18.31M |
| Free Cash Flow Yield | -2.07K% |